All biomedical research centres should have a lab devoted to understanding life. How did life come about? How did it evolve? How does it work?
Research Programmes / Core Facilities
Cell and Developmental Biology
Structural and Computational Biology
Chemistry and Molecular Pharmacology
Core Facilities & Services
Scientists at IRB Barcelona are supported by an extensive range of common core facilities that provide state-of-the-art technologies and scientific services. These facilities are a key asset for our research, allowing the Institute to obtain outstanding results. They are designed to incorporate the most novel technologies available and provide them to our researchers in the shortest time possible.
IRB Barcelona's partnerships, with organisations in areas of mutual interest and expertise, aim to take advantage of the wealth of knowledge, resources and technologies so critical to advancing the field of biomedicine
Selected IRB Barcelona publications
News & Events
Lluís Ribas: "We look for answers about the origin and evolution of life"
Discovery of a fundamental limit to the evolution of the genetic code
Researchers discover that breast cancer tumour growth is dependent on lipid availability
Identification of a new protein essential for ovule and sperm formation
31MayFrom Science to Business - BIST & ESADE Business School
01JunSonic hedgehog signalling controls the symmetry of neuroepithelial cell division
02JunPeptidomimetic POP inhibitors, towards a novel therapy for the treatment of cognitive impairment in schizophrenia
02JunUnintended consequences of targeted cancer therapy: Therapy induced tumor secretomes fuel drug resistance and tumor progression
Nature is constantly evolving—its limits determined only by variations that threaten the viability of species.
A study headed by the Institute for Research in Biomedicine (IRB Barcelona) and in collaboration with hospitals around Spain and the Universitat Rovira i Virgili (URV) has unveiled breast
Published today in Nature Communications, a study by scientists at the Institute for Research in Biomedicine (IRB Barcelona) headed by ICREA researcher Angel R.